Login
← Go Back
Glaxosmithkline Consumer Healthcare (Amalgamated)
GSKCONS · FMCG > Consumer Food · Chairman: P Dwarakanath · MD: Navneet Saluja · Listing date: Oct. 25, 1994
Stock Price vs Company Growth
1y
0.0%
5y
8.3%
10y
10.0%
all
19.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 10,733 0%
N/A
10,733
Company Overview
Sales
4,984 Cr
Growth: 6.8%
Profit after Tax
1,156 Cr
Growth: 5.1%
Large Cap
45,137 Cr
P/E: 39.1x
Industry P/E: 30.6x
Fundamentals
Sales (Cr) ₹ 4,984
Growth 6.8%
EBITDA 25.4%
P/S 9.1x
Dividend 0.0%
P/E 39.1x
Book Value ₹ 1,416
PEG Ratio 5.8x
ROE 21.0%
P/B 7.6x
Shareholding Pattern
Institutions
Lici New Endowment Plus-Balanced Fund
2.67 %
Promoters
Horlicks Limited
43.16 %
Glaxosmithkline Pte Limited
29.29 %
Others
Qualified Institutional Buyer
1.91 %
Iepf
0.19 %
Increase    Decrease    No change
Company Profile Detailed
Glaxosmithkline Consumer Healthcare’s (GCH) core business is manufacturing of health drinks under the brand Horlicks. The history of the company goes way back in 1950s when bottled Horlicks was imported from England. But in the year 1955 due to change in import policy, import of Horlicks was stopped. During 1956-57 a team of Horlicks visited India to explore possibilities for setting up a plant in India. For this the company approached Maharaja of Nabha, Pratap Singh in Punjab.
Belongs to (1 Indices)